2025
article
OpenAlex
Glauce Crivelaro Nascimento, Laurent Ferrié, Rita Raisman‐Vozari, Bruno Figadère et autres
br, fr
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Nathália Akemi Neves Kohara, Luís Fernando Fernandes Miranda, Pablo Pompeu Quini, Elaine Aparecida Del Bel et autres
Evidence supporting the clinical use of neuroprotective drugs for cerebral ischemia remains limited. Spatial and temporal disorientation, along with cognitive dysfunction, are among the most prominent long-term consequences of hippocampal neurodegeneration following cerebral ischemia. Cannabigerol (CBG), a non-psychotomimetic constituent of Cannabis sativa, …
br
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Bianca Andretto de Mattos, Rodrigo Hernán Tomas‐Grau, Thaís Antonia Alves Fernandes, Florencia González‐Lizárraga et autres
We aimed to simulate tau abnormalities-specifically hyperphosphorylation and aggregation-that are hallmarks of tauopathies, including Alzheimer's disease, to evaluate tau-targeting therapies. To model pathological p-tau accumulation at early disease stages, we exposed mouse cortical cultures to redox-active iron from hemin (Hm), a breakdown …
fr, br, ar, gp
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Aurore Tourville, Ismaïla Ciss, Rafaela Ribeiro Silva, Bianca Andretto de Mattos et autres
fr, br, us
(code pays fourni par la source)
2024
article
OpenAlex
Ana Carolina Issy, João Francisco Cordeiro Pedrazzi, Glauce Crivelaro Nascimento, Lúcia Helena Faccioli et autres
br
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Gabrielle A. Jacob, Bruna Araujo Milan, Livia Rodrigues Antonieto, Yara Loyanne de Almeida Silva Levi et autres
AIM: To investigate the hypothesis supporting the link between periodontitis and dopaminergic neuron degeneration. MATERIALS AND METHODS: Adult male Wistar rats were used to induce dopaminergic neuronal injury with 6-hydroxydopamine (6-OHDA) neurotoxin and experimental periodontitis via ligature placement. Motor function assessments were …
br
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Maurício dos Santos Pereira, Gabriel H Dias de Abreu, Leonardo Calaça Arruda Vanderlei, Rita Raisman‐Vozari et autres
fr, br, us
(code pays fourni par la source)
Accès ouvert
2024
preprint
OpenAlex
Ana Carolina Issy, João Francisco Cordeiro Pedrazzi, Glauce Crivelaro Nascimento, Lúcia Helena Faccioli et autres
Abstract The role of 5-lipoxygenase/leukotrienes on the central nervous system has been considered in both physiological end pathological states. Investigating the interaction between 5-lipoxygenase/leukotrienes and the dopaminergic system may provide better understanding of dopamine-related pathologies. This study aimed to investigate motor and …
br
(code pays fourni par la source)
2024
article
OpenAlex
Danilo Leandro Ribeiro, Rayanne Poletti Guimarães, Keila Bariotto‐dos‐Santos, Elaine Aparecida Del Bel et autres
Levodopa (L-DOPA) is the classical gold standard treatment for Parkinson's disease. However, its chronic administration can lead to the development of L-DOPA-induced dyskinesias (LIDs). Dysregulation of the nitric oxide-cyclic guanosine monophosphate pathway in striatal networks has been linked to deficits in corticostriatal …
br
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Glauce Crivelaro Nascimento, Maurício dos Santos Pereira, Igor Gustavo Carvalho Oliveira, Maria Eugênia Costa Queiroz et autres
Pharmacological manipulation of the endocannabinoid system represents a promising therapy to alleviate (L-DOPA)-induced dyskinesia (LID) in Parkinson's disease. We tested, here, whether cannabidiol (CBD), the major non-psychoactive constituent of Cannabis sativa, and HUF-101, a fluorinated CBD derivative could improve LID. We were …
br
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Bianca Andretto de Mattos, Glauce Crivelaro Nascimento, José Alexandre S. Crippa, Jorge Hallak et autres
Cannabidiol (CBD) and Cannabigerol (CBG) are phytocannabinoids with multiple pharmacological effects of potential therapeutic properties, such as neuroprotective, anti-inflammatory, antioxidant, and anti-excitotoxic. These phytocannabinoids could also be a promising therapy to alleviate or prevent L-3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesia (LID) in Parkinson’s disease (PD). …
br, fr
(code pays fourni par la source)
Accès ouvert
2022
preprint
OpenAlex
Bianca Andretto de Mattos, Jéssica Mendes Bonato, Elaine Aparecida Del Bel, Humberto Milani et autres
Abstract Purpose: The majority of animal models of Parkinson’s disease (PD) focus on motor symptoms that are induced by unilateral injections of such neurotoxins as 6-hydroxydopamine (6-OHDA) in nigrostriatal dopaminergic pathways. However, motor changes that are induced by unilateral 6-OHDA injections may …
br, pe
(code pays fourni par la source)